Related Experiment Video
Updated: May 25, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Creating public awareness: state 2025 diabetes forecasts
William R Rowley1, Clement Bezold
1Institute for Alternative Futures, Alexandria, Virginia 22314, USA. browley@altfutures.org
Population Health Management
|January 31, 2012
Summary
Diabetes prevalence is rising sharply, with significant increases projected. Early detection and lifestyle changes are crucial for prevention and managing diabetes complications.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Background:
- The incidence and prevalence of diabetes, particularly type 2 diabetes, have increased dramatically since 1990.
- Projections indicate a 64% rise in diabetes cases between 2010 and 2025, impacting over 53 million individuals and incurring substantial economic costs.
- While effective treatments and preventative measures exist, early detection of prediabetes and societal lifestyle changes are vital for reducing overall prevalence.
Purpose of the Study:
- To enhance public awareness regarding the severity of regional diabetes trends.
- To provide detailed state and metropolitan area forecasts for diabetes prevalence in 2010, 2015, and 2025.
- To inform stakeholders about the potential impact and costs of diabetes at local levels for better decision-making and resource allocation.
Main Methods:
- Development of a predictive model using the latest national diabetes and population data and projections.
- Transformation of national data into state and metropolitan area forecasts for the general population and key demographic subgroups.
- Summarization of forecasts into accessible briefing papers for public access online.
Main Results:
- Detailed forecasts for diabetes prevalence and associated costs at state and metropolitan levels have been generated.
- The study provides crucial data for understanding localized diabetes trends.
- Accessible briefing papers facilitate informed decision-making for stakeholders.
Conclusions:
- Addressing the escalating diabetes epidemic requires a comprehensive approach, including early detection, effective treatment, and significant societal lifestyle modifications.
- The generated state and metro-level data are essential for targeted public health interventions and resource management.
- Increased public awareness and data accessibility are key to mitigating the future impact of diabetes.
Related Concept Videos
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...